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http://dx.doi.org/10.1016/j.stemcr.2017.08.009SUMMARYThe production of insulin-producing b cells from human embryonic stem cells (hESCs) in vitro represents a promising strategy for a
cell-based therapy for type 1 diabetes mellitus. To explore the cellular heterogeneity and temporal progression of endocrine progenitors
and their progeny, we performed single-cell qPCR on more than 500 cells across several stages of in vitro differentiation of hESCs and
compared themwith human islets.We reveal distinct subpopulations along the endocrine differentiation path and an early lineage bifur-
cation toward either polyhormonal cells or b-like cells. We uncover several similarities and differences with mouse development and
reveal that cells can take multiple paths to the same differentiation state, a principle that could be relevant to other systems. Notably,
activation of the key b-cell transcription factor NKX6.1 can be initiated before or after endocrine commitment. The single-cell temporal
resolution we provide can be used to improve the production of functional b cells.INTRODUCTION
The generation of b cells from human pluripotent stem
cells (hPSCs) receives much attention due to the poten-
tial for developing a cell-based therapy for diabetesmellitus
and for use in drug discovery and disease modeling in vitro.
Considerable progress has been made in the development
of protocols for in-vitro-directed differentiation of hPSCs
toward b cells. While current protocols produce b-like cells
with some functionality (Pagliuca et al., 2014; Rezania
et al., 2014; Russ et al., 2015), the generated cells are not
fully mature and possess limited glucose responsiveness
(Johnson, 2016).
The design of stepwise directed differentiation protocols
to produce islet-like cells has relied heavily on knowledge
from pancreas developmental biology. While it is well
established that the five types of endocrine cells found in
the islets of the pancreas (a, b, d, ε, and PP cells) are derived
from a progenitor population characterized by transient
expression of NEUROG3 (Gu et al., 2002), it remains un-
known how the individual endocrine cell types are segre-
gated from this population. However, several studies in
mice and in vitro human embryonic stem cell (hESC) dif-
ferentiation suggest that b cells differentiate from a subset
of pancreatic progenitors expressing PDX1+ and NKX6.1+
that will turn on NEUROG3 (Kelly et al., 2011; Kroon
et al., 2008; Nelson et al., 2007; Rezania et al., 2013;
Schaffer et al., 2013).
In aiming to achieve the goal of producing stem
cell-derived fully functional b cells that closely resemble1246 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017 j ª 2017 Th
This is an open access article under the CC BY-NC-ND license (http://creativhuman primary b cells, the need for a deeper phenotyp-
ing of both human b cells and stem cell-derived cultures
has been emphasized (Johnson, 2016). Single-cell RNA
sequencing (RNA-seq) has recently been applied to char-
acterize single human islet cells (Baron et al., 2016;
Lawlor et al., 2017; Li et al., 2015; Muraro et al., 2016;
Segerstolpe et al., 2016; Wang et al., 2016; Xin et al.,
2016), but single-cell gene expression profiling of hPSC-
derived cultures differentiated toward the pancreatic
lineage has, to the best of our knowledge, not been re-
ported. Single-cell-based analysis offers the potential to
reveal heterogeneity in differentiated hPSC cultures
that can affect the propensity to differentiate into spe-
cific cell types.
To do so, we studied the formation of pancreatic
endocrine cells in vitro using a model system based on
differentiation of hESCs toward the pancreatic endo-
crine lineage. We analyzed more than 500 cells iso-
lated from several stages of differentiation by single-
cell qPCR and compared them with primary human
islet cells. The low noise of single-cell PCR enabled
us to establish a transcriptional map of the progres-
sive stages of differentiation during endocrine devel-
opment and uncovered prospective lineage trees for
cells fated to become either polyhormonal or b-cell
like. Integration of single-cell gene expression anal-
ysis with functional studies revealed multiple differ-
entiation paths to b-like cells through the initiation
of NKX6.1 expression either before or after endocrine
commitment.e Author(s).
ecommons.org/licenses/by-nc-nd/4.0/).
2.2 12.4
56.4 29.0
19.1
19.7
38.5
Definitive 
Endoderm
Primitive 
gut tube
Posterior 
foregut
Pancreatic 
progenitors
Stage 5
3d
Stage 6
7d
Stage 7
7d
Stage 1
3 d
Stage 2
2 d
β-like
Chir
AA
FGF7
VitC
FGF7
VitC
1uM RA
SANT1 (HHi)
TPB
LDN (BMPi)
FGF7
VitC
100 uM RA
SANT1 (HHi)
TPB
LDN (BMPi)
SANT1 (HHi)
50 nM RA
ALK5i II (TGFβi)
T3
LDN (BMPi)
ALK5i II (TGFβi)
T3
LDN (BMPi)
y-sec. Inh XX
Heparin
ALK5i II (TGFβi)
T3
N-acetyl-cys
AXLi (R428)
Trolox (Vit E ana.)
Heparin
Stage 4
3d
Endocrine
progenitors
Stage 3
3d
Immature
endocrine
A
B
S4d
1
S4d
3
S5d
3
S6d
2
S6d
7
S7d
7
0
20
40
60
80
100
%
of
to
ta
lp
op
ul
at
io
n
NEUROG3
NKX6.1
NKX2.2
NEUROD1
PAX6
PDX1
D
F
hESC
C
E
N
KX
6.
1
C-peptide
G
lu
ca
go
n
C-peptide
GCG C-pep DAPI
NEUROG3-eGFP
Ghrelin C-pep DAPI
NEUROG3-eGFP
PPY C-pep DAPI
NEUROG3-eGFP
SST C-pep DAPI
NEUROG3-eGFP
NKX6.1 C-pep DAPI
NEUROG3-eGFP NKX6.1 C-pep
G
0
10
20
30
40
50
C-pep+/GCG-
%
 o
f t
ot
al
 p
op
ul
at
io
n
%
 o
f t
ot
al
 p
op
ul
at
io
n
0
10
20
30
40
C-pep+/NKX6.1+
S4d
1
S4d
3
S5d
3
S6d
7
S7d
7
0
10
20
30
40 NEUROG3+
SA121
NEUROG3-eGFP
S4d
1
S4d
3
S5d
3
S6d
7
S7d
7
S4d
1
S4d
3
S5d
3
S6d
7
S7d
7
C-pep+/GCG-
%
of
to
ta
lp
op
ul
at
io
n C-pep+/GCG+
C-pep-/GCG+
C-pep+/NKX6.1+
SST
0
10
20
30
40
50
S4d
1
S4d
3
S5d
3
S6d
2
S6d
7
S7d
7
Figure 1. Generation of Pancreatic Endocrine Lineage Cells from hESCs
(A) Overview of 7-stage differentiation protocol.
(B and C) Flow-cytometry quantification of various transcription factors (B) and hormones (C) at six distinct stages of the differentiation
protocol. Data are presented as individual biological replicates with error bars representing the mean (n = 3–7 except in C: S6d2 for
C-peptide [C-pep]/NKX6.1 n = 1 and SST n = 2).
(D) Representative FACS plots for C-pep and NKX6.1 or C-pep and GCG in differentiated hESCs at S7d7.
(E and F) Immunofluorescence staining at S7d7 for EGFP, C-pep and NKX6.1 (E) or EGFP, C-pep, and the hormones GCG, ghrelin, PPY, or SST
(F). Nuclei stained with DAPI. Scale bars, 50 mm.
(legend continued on next page)
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RESULTS
In Vitro Generation of Pancreatic Endocrine
Progenitors
To model human pancreatic endocrine development,
we used an established 7-stage directed differentiation
protocol (Rezania et al., 2014) with minor modifications
(Figure 1A and Experimental Procedures) and a hESC
line expressing EGFP under the control of the endoge-
nous NEUROG3 locus (NEUROG3-EGFP) (Lo¨f-O¨hlin et al.,
2017). Similarly to several other lines, the NEUROG3-
EGFP line differentiated efficiently to definitive endoderm
and pancreatic progenitors, displayed robust endocrine in-
duction marked by NEUROG3 protein expression during
stages 4 and 5, and more mature endocrine cell differentia-
tion at later stages (Figures S1A and S1B). At the final stage
of the protocol we observed both C-peptide+/glucagon
cells (b-like) and C-peptide+/glucagon+ cells (polyhormo-
nal). Fifty-one percent of the C-peptide+ cells co-expressed
the b-cellmarker NKX6.1 (Figures 1B–1E).We also observed
some somatostatin+ cells and rare cells expressing the hor-
mones PPY or ghrelin (Figures 1C and 1F).
The longer half-life of GFP (Corish and Tyler-Smith,
1999) compared with NEUROG3 (Roark et al., 2012) leads
to a decreased overlap with time and thus enables the
capturing of cells that no longer express NEUROG3 but
retain EGFP (Figures S1C–S1E). Conversely, the EGFP/
NEUROG3+ cells present at all stages (Figures S1D–S1F)
are likely newly born NEUROG3+ cells that have not yet
accumulated enough EGFP protein to be detected, an inter-
pretation confirmed by subsequent analysis below. Most
EGFP+ cells co-expressed NKX2.2, indicating progression
into the endocrine lineage (Figure S1G).
Importantly, although the NEUROG3-EGFP hESC line
used in this study is NEUROG3 haploinsufficient, it differ-
entiated into endocrine progenitors and endocrine cells
with efficiency similar to that of the parental cell line
SA121 (Heins et al., 2004) (Figures 1G and S1H).
Together, these results demonstrate that we could reca-
pitulate many aspects of the published protocol with the
NEUROG3-EGFP line.
Transcriptional Profiling of Individual Endocrine
Progenitors and Their Progeny
To explore heterogeneity within the endocrine progenitor
population, we isolated NEUROG3-EGFP+ and EGFP cells
at stage 4 day 1 (S4d1), when the first NEUROG3-EGFP+(G) FACS quantification of the percentage of cells expressing C-pep+/G
of the NEUROG3-EGFP reporter cell line (heterozygous for NEUROG3;
presented as mean ± SD (n = 3 biological replicates).
See also Figure S1.
1248 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017cells appeared, and at S4d3, S5d3, S6d2, S6d7, and S7d7,
and analyzed them by single-cell qPCR (Figures 2A and
S2A). In total, 546 cells were analyzed by single-cell qPCR
for the expression of 86 genes, with 517 cells remaining
for analysis after quality control assessment (Figure S2).
The selection of genes encompassed key transcription
factors involved in endocrine development and specifica-
tion in the mouse, genes differentially expressed between
mature human endocrine subtypes, and reporters for five
major signaling pathways (Supplemental Experimental
Procedures).
Whenvisualizing thedatausingdimensionality reduction
via t-distributed stochastic neighbor embedding (t-SNE)
(Van Der Maaten and Hinton, 2008), the cells grouped in
three major clusters (Figures 2B and S3A) classified as (1)
pancreatic progenitors (SOX9+), (2) early endocrine progen-
itors (NEUROG3+), and (3) late endocrine progenitors and
endocrine cells (CHGA+) (Figures 2B–2D). Hierarchical clus-
tering separated the cells into similar groups (Figure 2D).
The pancreatic progenitors, which included most of the
sorted EGFP cells (regardless of stage), expressed pancre-
atic progenitor markers such as PDX1, SOX9, ONECUT1,
NOTCH1, and HES1 but did not express NEUROG3 (Figures
2C and 2D). The second cluster consisted of mainly stage-4
cells and represented early endocrine progenitors expressing
NEUROG3 and PAX4 but no hormones (Figures 2B and 2C).
Nearly all EGFP+ cells sorted at S4d1 contained NEUROG3
transcript (97%), but the proportiondecreasedduring differ-
entiation (Figures S3C and S3D). Most of the cells that had
NEUROG3 transcript came from stages 4 and 5, confirming
our flow-cytometry analysis (Figures 1B and S1D–S1F). The
third cluster contained stage-5 and -6 NEUROG3+ cells and
maturing endocrine cells from stages 6 and 7. This cluster
was characterized by high expression of INS and CHGA
withmost cells co-expressingGCG at varying levels (Figures
2B and2C). Cells divided into twomajor lineages expressing
either NKX6.1 and PDX1 or ARX and high levels of GCG
(Figure 2C).
Distinct Pancreatic Progenitor Populations
A combination of t-SNE analysis, overlap of gene expres-
sion, and prior knowledge of gene expression hierarchy
in mice enabled us to define several subtypes in each
of the three clusters. Pancreatic progenitors transitioned
from a state with no NKX6.1 transcripts at S4d1 to
most cells expressing NKX6.1 as well as MNX1 and other
markers at S4d3 and S5d3 (Figure 3A). At S4d1, pancreaticCG, C-pep+/NKX6.1+, and NEUROG3 throughout the differentiation
green bars) and the parental cell line SA121 (blue bars). Data are
AD
B C
Figure 2. Single-Cell qPCR Analysis of Differentiated Endocrine Progenitors and Progeny
(A) Schematic showing the experimental setup. NEUROG3-EGFP hESCs were differentiated in vitro and NEUROG3-EGFP+ cells were sorted by
FACS at the indicated time points for single-cell qPCR analysis.
(B) t-SNE analysis of 517 cells sorted from six time points during differentiation. Each dot represents a single cell and is colored according
to differentiation stage with shape according to EGFP status (circle, EGFP+; triangle, EGFP).
(C) t-SNE plots colored according to gene expression level of the indicated genes.
(D) Heatmap showing the expression level of 82 genes. Samples are displayed in columns and genes in rows. Data are clustered using
average linkage method and distances calculated with Pearson correlation for samples and Euclidean distance for genes. The bars above
the heatmap are color coded according to the level of EGFP protein expression in the individual sorted cell (top bar) and sample stage
(legend continued on next page)
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progenitors expressed moderate levels of RFX6, SIM1,
INSM1, and HADH (Figure 3A), which decreased at S4d3
and were lost at S5d3. Notably, these markers simul-
taneously became restricted to endocrine cells, as seen in
mice for RFX6 (Soyer et al., 2010). Sim1 and Hadh are like-
wise expressed during mouse pancreas development, but
their cell-type-specific expression patterns have not been
characterized (White et al., 2008).
EGFP progenitors persisted beyond stage 5 but formed
a heterogeneous group of cells, of which some appear to
be misrouted toward different organ lineages. Some of
these cells lacked PDX1 expression and instead expressed
the intestinal marker CDX2 (Figure S3B). Expression of
ONECUT1 decreased with time, so that stage-7 EGFP pro-
genitors were largely negative, whereas HES1 and SOX9
decreased only in a subset of cells (Figure 3D). The simulta-
neous gain of CHGA and INS expression in the EGFP
population at S7d7 indicates that virtually all cells in
the culture at this stage have initiated some level of endo-
crine differentiation (Figure 3D). However, the low levels
of CHGA and INS and the rare expression of NKX2.2,
NEUROD1, and PAX6 (Figure 3D) suggest that these cells
have not committed fully to the endocrine lineage, or are
perhaps reverting.
Heterogeneity within the NEUROG3+ Endocrine
Progenitor Population
Many genes were differentially expressed in endocrine
progenitors between stage 4 and later stages, but we also
observed contemporary subpopulations, suggesting that
cells do not differentiate at the same pace or indicating
the existence of lineage bifurcations. At S4d1, a population
of NEUROG3+ cells co-expressed the pancreatic progenitor
markers SOX9, HES1, and ONECUT1 and is expected to
represent the first step of endocrine commitment (Fig-
ure 3A). These cells did not express NKX6.1, in agreement
with the absence of NKX6.1 in pancreatic progenitor
cells at S4d1 (Figure 3B). In addition, these cells expressed
NKX2.2 and RUNX1T1, which appear to be the first
NEUROG3 targets. At the same stage, a more mature popu-
lation was identified with PAX4, MAFB, NEUROD1, low
CHGA, andGCK additionally induced while the progenitor
markers SOX9, HES1, and ONECUT1 were downregulated.
While most EGFP pancreatic progenitors expressed
NKX6.1 at S4d3, only a subset of EGFP+ cells had NKX6.1
transcripts (Figure 3B) and none expressed NKX6.1 pro-
tein at this stage (Figure 3C), indicating that the early
NEUROG3+ cells do not derive from an NKX6.1+ popula-(bottom bar). Gray bars below the heatmap indicate the correspondin
below the heatmap. The cells originate from three independent biolog
days, in similar proportions, with no batch effect.
See also Figures S2 and S3.
1250 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017tion. The presence of NKX6.1 transcripts in some EGFP+
cells suggests the initiation of NKX6.1 expression after
endocrine commitment. At S4d3, a NEUROG3+ population
co-expressed pancreatic progenitor markers, suggesting
that these cells entered the differentiation pipeline at this
stage. These cells also expressedNKX6.1, unlike their coun-
terpart at S4d1, as well as PAX4, MAFB, NEUROD1, CHGA,
GCK, and low levels of PAX6 and FEV. They likely originate
from NKX6.1+/MNX1+ pancreatic progenitors. Two other
more mature populations of endocrine progenitors ex-
pressed NEUROG3 but no pancreatic progenitor markers.
None expressed NKX6.1, and they thus likely derive from
the NKX6.1 progenitors present earlier. While the most
abundant group expressed PAX6, FEV, and low MNX1,
the other expressed ISL1 and ETV1 (Figure 3A). A popula-
tion expressed similar markers to the second but more
NEUROG3 targets such as PAX6 and ARX, as well as low
levels of insulin, while the levels of NEUROG3 and PAX4
were reduced. This suggests a maturation step further
representing the first transition to hormone expression.
Taken together, these findings suggest a divergence of dif-
ferentiation trajectories during stage 4.
The expression level of NEUROG3 (both mature and
nascent mRNA transcript) and EGFP peaked in endocrine
progenitors of stage 5 (Figure 3A). Endocrine progenitors
and progeny continued to mature at S5d3, increasing
CHGA and expressing the hormone INS as well as MNX1,
PAX6, FEV, ISL1, PCSK2, and TSPAN1. NKX6.1 expression
partitioned two different NEUROG3+ populations: a large
population characterized by NKX6.1+, HADH+, and low
levels of PCSK1 expression while having low or no expres-
sion of SST and GCG hormone transcripts, and a smaller
group of NKX6.1 cells that had higher levels of GCG or
SST, co-expressedARX, butnotHADH (Figure3A).Addition-
ally, a population of immature endocrine cells was present
at stage 5 that had turned off NEUROG3, while some had
also lost PAX4 expression. Most of these cells expressed
NKX6.1 and PCSK1. Endocrine progenitors were also found
at stage 6, although they had lower levels of NEUROG3 and
PAX4 than those found at stages 4 and 5. These cells were
similar to the NKX6.1+ endocrine progenitors at stage 5,
but additionally expressed ISL1, more robust PCSK1, and
moderate levels of GCG (Figure 3A).
Co-transcription of Multiple Hormones during
In Vitro Differentiation
We observed a substantial co-expression of multiple hor-
mone transcripts during the in vitro differentiation ofg clusters in the t-SNE in (B). Major cell populations are indicated
ical replicates of the entire differentiation, carried out on different
AB C
D
(legend on next page)
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hESCs. As early as S4d1, low levels of ghrelin transcripts
were detected inNEUROG3+ cells but not in pancreatic pro-
genitors (Figure 3A). The next hormone transcripts appear-
ing were SST and INS at S4d3, followed by GCG. Ghrelin
transcripts were expressed in a surprisingly large propor-
tion of endocrine committed cells until stage 7, when
expression was lost in most cells. PPY transcripts were de-
tected in a few cells from S5d3 and beyond (Figure 3A).
Most INS+ cells co-expressed GCG and/or SST transcripts
at varying levels from stage 6 onward (Figures 2C and 3A),
although this transcriptional co-expression does not lead
to detectable hormone production in most cells (Figures
1C and 1D). We speculate that cells with high GCG tran-
script levels and ARX expression are also bihormonal at
the protein level, as seen during human development
(Jeon et al., 2009; Riedel et al., 2012), whereas cells with
NKX6.1 expression and often lower levels of GCG will not
express detectable levels of glucagon protein. Alternatively,
a post-transcriptional regulation may occur. Cells did not
seem to mature much during stage 7; on the contrary,
many genes important for b-cell identity were expressed
at higher level at S6d7 compared with S7d7, including
NKX6.1 and PCSK1. At S6d7 many endocrine cells dis-
played a b-cell-like profile, expressing INS, NKX6.1 MNX1,
PCSK1, PCSK2, NPTX2, HADH, and some MAFA and IAPP.
Such a population was also found at S7d7, although
smaller, whereas the largest endocrine population at S7d7
had decreased levels of NPTX2 and HADH, and only spo-
radic cells expressed MAFA and IAPP (Figure 3A).
Early Endocrine Progenitors Initiate NKX6.1
Expression Downstream of NEUROG3
Our single-cell qPCR analysis suggested a potential branch-
ing point during differentiation of NEUROG3+ endocrine
progenitors between stages 4 and 5 characterized by theFigure 3. Distinct Cell Populations Identified at Each Stage of Di
(A) Heatmap displaying the gene expression level in 517 single cells w
Samples are displayed in columns and genes in rows. Data are clust
Pearson correlation for samples (per stage) and Euclidean distance for
level of EGFP protein expression in the individual sorted cell (top bar) a
are indicated below the heatmap with their associated key transcript
genitors; light-green cells represent newly formed endocrine progenit
represent immature endocrine cells; dark-purple cells represent endo
lineage relationships between the cell types at different time points
(B) Scatterplot showing the level of NKX6.1 transcript in NEUROG3
expression and error bars represent SD (number of cells is shown in
NEUROG3-EGFP+/ cells with NKX6.1 expression >0.
(C) Representative flow-cytometry plot showing expression of NEURO
indicate percentage of cells.
(D) Violin plots for the distribution of gene expression per stage of
NEUROG3-EGFP population. The cells originate from three independe
different days, in similar proportions, with no batch effect.
See also Figure S3.
1252 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017acquisition ofNKX6.1 transcript. As early endocrine induc-
tion in NKX6.1 cells in hPSC-derived cultures has been
proposed to give rise to INS+/GCG+ polyhormonal cells
in vitro and a-like cells upon engraftment in mice (Kelly
et al., 2011; Rezania et al., 2013), we sought to investigate
the potential of endocrine progenitors formed during stage
4 and those born during stage 5 or thereafter. No cells
expressed NKX6.1 protein at S4d1 (Figure 4A) and the tran-
script was restricted to 10% NEUROG3-EGFP+ cells (Fig-
ure 3B). NKX6.1 was restricted to some NEUROG3-EGFP
cells at S4d3 but was excluded from NEUROG3+ and
NEUROG3-EGFP+ cells, although many had NKX6.1 tran-
scripts (Figure 4A). NKX6.1 and NEUROG3-EGFP were
co-expressed by 31% ± 8% of the total cell population at
S5d3. As most EGFP+ cells at S4d3 expressed NKX2.2 pro-
tein (Figure S1G), this suggests that they have initiated
a transcriptional program downstream of NEUROG3 and
are committed to the endocrine lineage. These findings sug-
gest that NKX6.1 expression can be acquired downstream
of NEUROG3 expression and endocrine commitment.
To explore this further, we isolatedNEUROG3-EGFP+ and
EGFP cells by fluorescence-activated cell sorting (FACS) at
S4d3, and cultured the two populations further in stage-5
media to test their fate. Due to the limited number of
cells we could retrieve from sorting and to have sufficient
numbers of cells for later analysis, we co-cultured the sorted
cells with S4d3 cells derived from the SA121 hESC line
differentiated in parallel (Figure 4B and Supplemental
Experimental Procedures). After 3 days of culture, cells
were fixed and stained for NKX6.1. Immunofluorescence
staining and flow cytometry revealed the presence of
NEUROG3-EGFP+ cells in the cultures with sorted S4d3
NEUROG3-EGFP+ cells, showing that cells can retain
EGFP reporter signal for at least 3 days (Figures 4C and
4E). NEUROG3-EGFP+ cells were similarly detected in thefferentiation
ithin each of the six stages of differentiation for 45 selected genes.
ered using average linkage method and distances calculated with
genes. The bars above the heatmap are color coded according to the
nd sample stage (bottom bar). Cell populations found at each stage
ion factors and other markers. Blue cells represent pancreatic pro-
ors; green cells represent endocrine progenitors; light-purple cells
crine cells. Red nuclei indicate NKX6.1+ expression. The proposed
are shown below.
-EGFP+/ cells from each stage. Horizontal line represents mean
Figure S3C). Numbers above each plot indicate the percentage of
G3-EGFP and NKX6.1 at S4d3 and S5d3. Numbers in each quadrant
the indicated genes in the NEUROG3-EGFP+ population versus the
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Figure 4. NKX6.1 Is Induced Downstream of NEUROG3
(A) Flow-cytometry analysis of co-expression of NEUROG3-EGFP and NKX6.1 at S4d1, S4d3, and S5d3 (black bars, mean ± SD, n = 3) or
NEUROG3 and NKX6.1 (white bars, mean ± SD, n = 2).
(B) Schematic showing the experimental setup. NEUROG3-EGFP+/ cells were sorted at S4d3, mixed with SA121 hESC differentiated in
parallel, and cultured in either 2D or 3D to S5d3. Cells were then analyzed for EGFP and NKX6.1 expression.
(C and D) Immunofluorescence staining for EGFP and NKX6.1 of S4d3 sorted NEUROG3-EGFP+ cells (C) and NEUROG3-EGFP cells (D) 2 hr
and 72 hr after plating in 2D. White arrows indicate NKX6.1+/EGFP+ cells. The yellow arrow marks a single weak EGFP+ cell. Scale bars,
100 mm; scale bars in enlargements, 20 mm.
(E and F) Representative FACS plots for NKX6.1 and NEUROG3-EGFP for S4d3 sorted NEUROG3-EGFP+ cells (E) and NEUROG3-EGFP cells (F)
cultured in 3D for 72 hr (to S5d3).
(G) Flow-cytometry quantification of NEUROG3-EGFP+/ cells sorted at S4d3 and analyzed at S5d3 after 72 hr of culturing in 3D for
co-expression of NEUROG3-EGFP and NKX6.1. Data represent mean ± SEM (n = 3 for S4d3 NEUROG3-EGFP+-derived cells and n = 2 for S4d3
NEUROG3-EGFP-derived cells). n refers to biological replicates of the entire differentiation, carried out on different days.
See also Figure S4.cultures with sorted S4d3 NEUROG3-EGFP cells, demon-
strating that new NEUROG3+ cells arise during stage 5
(Figures 4D and 4F). Among these, 65% ± 3% co-expressedNKX6.1, as revealed by flow-cytometry analysis of 3D
cultures (Figure 4G). While S4d3 NEUROG3-EGFP+ cells
had minimal co-expression of NKX6.1, many of the sortedStem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017 1253
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Figure 5. Early- and Late-Born Endocrine Progenitors Both Give Rise to NKX6.1+/C-pep+ Cells at S7d7
(A) Schematic showing the experimental setup. NEUROG3-EGFP+/ cells were sorted at S4d3, mixed with SA121 hESC differentiated in
parallel, and cultured in 2D to S7d7. Cells were then fixed and stained at S7d7 for EGFP, NKX6.1, C-pep, and GCG.
(legend continued on next page)
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S4d3 EGFP+ cells expressed NKX6.1 when analyzed at
S5d3 by flow cytometry (40% ± 17%) (Figures 4E and 4G)
or immunocytochemistry (Figures 4C, 4D, and S4A). We
thus conclude that NEUROG3-EGFP+ cells are born during
stages 4 and 5, and our sorting experiment further demon-
strates that NKX6.1 can be acquired in cells after they have
initiated NEUROG3 expression.
Early- and Late-Born Endocrine Progenitors Have the
Same Developmental Potential
Next, we explored whether acquiring NKX6.1 downstream
of NEUROG3 would enable the generation of b-like cells.
We co-cultured EGFP+ or EGFP cells sorted at S4d3 with
SA121 to S7d7 and found that both early- and late-formed
NEUROG3-EGFP+ cells gave rise to EGFP+ cells that co-
expressed C-peptide and NKX6.1 at S7d7 (Figures 5A and
5B). Additionally, both populations gave rise to NKX6.1+
progeny that did not express C-peptide as well as C-pep-
tide+ cells devoid of NKX6.1. Likewise, we detected EGFP
expression in C-peptide+/glucagon+ cells, C-peptide+/
glucagon, cells and very rare C-peptide/glucagon+ cells
derived from both populations of endocrine progenitors
(Figure 5C). Early- and late-born endocrine progenitors
thus have a similar potential to generate C-peptide+/
NKX6.1+ or C-peptide+/GCG+ cells in vitro.
We additionally co-cultured EGFP+ or EGFP cells sorted
at S4d3 with likewise differentiated SA121 cells in 3D at the
air-liquid interface and FACS isolated NEUROG3-EGFP+
cells at S7d7 for single-cell qPCR (Figure 6A). Among the
41 S4d3 EGFP+-derived cells and 38 S4d3 EGFP-derived
cells that passed quality assessment, ANOVA analysis
comparing the two populations identified seven slightly
differentially expressed genes, including INS, GCG, and
HADH (Figures 6B and S4D), but this did not lead to a segre-
gation of the two populations in t-SNE (Figure 6C) and
hierarchical clustering (Figure 6D). Hierarchical clustering
using selected genes important for b-cell identity separated
the data into a cluster characterized by co-expression of
INS and GCG transcripts, while the other had low or no
GCG transcripts in addition to expression of INS, NKX6.1,
PDX1, PCSK1, and HADH (Figure 6D). Importantly, cells
derived from both early- and late-born endocrine progeni-
tors contributed to both populations.
In summary, these experiments reveal that NEUROG3-
EGFP cells born during stage 4 have the potential to give
rise to the same cell types as those born during or after stage
5. NEUROG3-EGFP+ cells devoid of NKX6.1 protein can(B and C) Immunofluorescence staining at S7d7 of S4d3 sorted NEURO
SA121 cells. (B) Staining for EGFP, NKX6.1, C-pep, and DAPI. White
NKX6.1; yellow arrows, EGFP+/C-pep+/NKX6.1+. (C) Staining for EGF
arrowheads, EGFP+/C-pep/GCG; yellow arrows, EGFP+/C-pep+/GCG+;
in insets in (B), 12.5 mm.acquire it after endocrine commitment and become INS+/
GCG-low/negative cells that further express b-cell markers
such as PCSK1, IAPP, and HADH.
To further investigate the profile of endocrine pro-
genitors giving rise to INS+/NKX6.1+ cells versus GCG+/
INS+/NKX6.1 cells, we compared early- and late-born
NEUROG3-EGFP+ cells generated with the described
7-stage protocol (‘‘new’’) with corresponding cells pro-
duced using an earlier developed 4-stage protocol (‘‘old’’),
which gives rise to mostly polyhormonal GCG+/INS+/
NKX6.1 cells in vitro (Rezania et al., 2012) (Figure S5). Cells
at the late stage of the old protocol had lost NEUROG3
expression with most cells co-expressing INS, GCG, and
ARX, whereas NKX6.1, MNX1, HNF1A, and PCSK2 tran-
scripts were largely confined to the new protocol (Figures
S5B and S5C). Interestingly, most early endocrine progeni-
tors of the old protocol expressed ISL1 but not FEV, whereas
only a smaller subset of NEUROG3+ cells from the new
protocol expressed ISL1. At the late stage, cells of the old
protocol all expressed ISL1 and lower levels of FEV, whereas
cells of the new protocol had FEV but not all had ISL1.
This is coherent with our earlier observations suggesting
that FEV expression before ISL1 in endocrine progenitors
marks cells on the b-cell path, while ISL1 onset before
FEV appears to predict the polyhormonal INS+/GCG+/
ARX+/NKX6.1 profile seen at the end of the old protocol.
Transcriptional Similarities and Differences between
In-Vitro-Generated b-like Cells and Adult Human b
Cells
To assess the similarity between cells produced in vitro to
mature islet cells, we performed single-cell qPCR on 165
human islet cells, encompassing a (107), b (18), PP (8),
d (2), cells and a group of non-endocrine cells (30), of which
22 had a ductal gene expression profile and 8 had a mesen-
chymal profile (Figure S6). Comparison between the
different cells is presented in Figure S6 and the main find-
ings are reported in Supplemental Information.
We next compared the human islet single-cell data with
that of hESC-derived cells. T-SNE analysis showed that the
non-endocrine cells from human islets clustered closely to
the pancreatic progenitor cells, the b cells were in prox-
imity to the stage-6 and -7 cells, and the a and PP cells
formed a cluster on their own at equal distance to all other
cells (Figure 7A). We then compared the gene expression
profile of human a and b cells with hESC-derived INS+ cells
divided into four groups based on hierarchical clusteringG3-EGFP+ cells and NEUROG3-EGFP cells cultured in 2D along with
arrows, EGFP+/C-pep/NKX6.1+; white arrowheads, EGFP+/C-pep+/
P, C-pep, GCG, and DAPI. White arrows, EGFP+/C-pep+/GCG; white
yellow arrowheads, EGFP+/C-pep/GCG+. Scale bars, 50 mm; scale bar
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Figure 6. Potential of hESC-Derived Endocrine Progenitors
(A) Schematic showing the experimental setup. NEUROG3-EGFP+/ cells were sorted at S4d3, mixed with SA121 hESC differentiated in
parallel, and cultured in 3D to S7d7. Cells were then sorted by FACS at S7d7, and EGFP+ cells collected for single-cell qPCR analysis.
(B) Violin plot showing the distribution of gene expression level of seven genes differentially expressed based on ANOVA analysis between
single EGFP+ cells at S7d7 derived from early- or late-born endocrine progenitors.
(C) t-SNE analysis of EGFP+ progeny at S7d7 from early- or late-born endocrine progenitors.
(D) Heatmap showing the expression level of selected genes in EGFP+ progeny at S7d7. The cells originate from three independent bio-
logical replicates of the entire differentiation, carried out on different days, in similar proportions, with no batch effect.
See also Figure S5.(Figure S6F). One group represented polyhormonal cells,
while cells with a more b-cell-like profile were divided
into three groups based on maturation stage: b-like
(NEUROG3/EGFP), immature b-like (NEUROG3/EGFP
low), and early immature b-like (NEUROG3+/EGFP+) (Fig-
ures 7B and S6F). Analyzing the expression of genes en-
riched in human b cells, we found equal levels of PTCH1,
RUNX1T1, TSPAN1, RGS16, DLK1, PDX1, MNX1, and
NKX6.1 between human b cells and the three groups
of b-like cells (Figure 7C). INS expression was highest in
b cells, followed by b-like cells, polyhormonal cells, and
finally the two groups of immature b-like cells. PCSK11256 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017was expressed in b cells and all b-like and immature b-like
cells, whereas just a subset of the early immature b-like cells
had PCSK1 (Figure 7B). These findings show that a subset of
the in-vitro-generated cells share important transcriptional
identity with primary human b cells.
Nevertheless, we also identified genes differentially
expressed between b cells and hESC-derived cells. These
included GPM6A, MAFA, HDAC9, IAPP, and HADH, which
were expressed in all b cells at much higher level compared
with even themostmature b-like cells (Figure 7D), showing
a lack of maturity of in-vitro-produced cells. On the con-
trary, KRT19 was expressed at higher level in hESC-derived
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Figure 7. Comparison of Human Adult b and a Cells with hESC-Derived INS+ Cells
(A) t-SNE plot of hESC-derived cells colored by stage and human islet cells colored by cell type.
(B) t-SNE plot of human a and b cells along with hESC-derived INS+ cells categorized as polyhormonal, b-like, immature b-like, and early
immature b-like.
(legend continued on next page)
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cells compared with human a and b cells, whereas PRDM16
was exclusive to the hESC-derived cells, indicating that
these markers represent immaturity. The a-cell-enriched
genes ARX and FEVwere expressed at equal levels in a cells
and polyhormonal cells, whereas FEVwas also expressed in
b-like cells, with higher expression in the immature sub-
groups (Figure 7E). GCG was expressed at very high level
in all a cells, more heterogeneously in polyhormonal cells,
lower in b-like cells, and lowest in b cells (Figure 7E).
Finally, we explored the expression pattern of genes
equally expressed in human a and b cells. MAFB, PAX6,
and INSM1 were expressed at similar level in a, b, and
hESC-derived cells (Figure 7F). ETV1 was expressed in all
a, b, and polyhormonal cells, but only in a subset of
b-like cells. PCSK2 was expressed at similar level in all cells,
though slightly higher in a cells. HOPX was expressed in
a and b cells and most hESC-derived b-like cells, but only
in some immature b-like cells and polyhormonal cells.DISCUSSION
In this study, we present a comprehensive characterization
of hESC-derived human pancreatic endocrine progenitors
and their progeny by use of single-cell qPCR and compare
their transcriptional profile with that of primary human
islet cells. Our single-cell analysis identifies subpopulations
among pancreatic progenitors, endocrine progenitors, and
endocrine cells during directed differentiation of hESCs
toward the pancreatic endocrine lineage. These observa-
tions enable us to delineate progression steps along the
differentiation path and prospective differentiation trajec-
tories. We find that MNX1 and NKX6.1 distinguish popu-
lations of pancreatic progenitor cells at S4d1 and S4d3,
and newly identify the expression of SIM1, RFX6, INSM1,
and HADH in early human pancreatic progenitors. We
find that hormone expression is already initiated in the
NEUROG3+ cells. Signs of lineage bifurcations and conver-
gence among endocrine progenitors were observed as early
as S4d3, with distinct gene expression signatures between
endocrine progenitor subpopulations based on MNX1,
NKX6.1, ARX, FEV, and ISL1. These bifurcations lead to
different populations of endocrine cells at stages 6 and 7,
manifesting with either a polyhormonal signature (high
INS and GCG, ARX+) or a b-cell signature (high INS and(C–F) Box-and-whisker plots showing gene expression in a-, b-, and
derived b-like cells (C), genes differentially expressed in b-cell and
expressed at equal levels in both a and b cells (F). The boxes repre
1.5 times interquartile range from Q1 and Q3.
(G) Model of in vitro endocrine differentiation toward the two major
originate from three independent biological replicates of the entire d
The islet cells originate from a single individual with high-quality ex
See also Figures S6 and S7.
1258 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017PCSK1+, NKX6.1+). Furthermore, our findings uncover a
very long period of continuous NEUROG3 induction and
co-expression of multiple hormonal transcripts during
in vitro hESC differentiation.Endocrine Lineage Trajectories Suggest Multiple
Routes to b-like Cells
The marker overlap between populations and informa-
tion frommouse pancreas development leads us to propose
a general endocrine maturation sequence where inter-
mediate, possibly plastic states are identified. While newly
born endocrine progenitors expressing NEUROG3 retain
pancreatic progenitor markers (SOX9, ONECUT1, HES1,
NOTCH1/2), the first endocrine markers initiated down-
stream of NEUROG3 are RUNX1T1 and NKX2.2, followed
by PAX4 and NEUROD1 and subsequently CHGA, GCK,
and the prohormone convertases PCSK1/2. These tran-
scription factors are NEUROG3 targets in mice and may
be activated with different kinetics (Benitez et al., 2014).
In addition, we provide evidence for early lineage bifur-
cation at S4d1 or S4d3. This bifurcation may already occur
at S4d1 between newly formed endocrine progenitors
(still retaining most pancreatic progenitor markers) ex-
pressingMNX1, but not PAX4 orNEUROD1 and a large pop-
ulation of PAX4+,NEUROD1+,MNX1 cells (Figures 3A and
S7). These two populations may form independently or
may be steps on the same path, as suggested by the matu-
rity profile, whichwould imply the loss ofMNX1 as the first
populationmatures into the latter. The S4d1MNX1+ popu-
lation will likely give rise to themore matureMNX1+ endo-
crine progenitors found at S4d3, which express markers of
progression along the endocrine path (PAX4, NEUROD1,
and PAX6) as well as a new marker, FEV (Figures 3A and
S7). Likewise, the S4d1 MNX1 endocrine population is
proposed to give rise to the MNX1 population at S4d3
that expresses ISL1 but not FEV, and progresses further to
ARX+ cells, as NEUROG3 and PAX4 transcript levels are
downregulated. We cannot rule out that the S4d1 MNX1
population might also contribute to the b-cell fated line-
age, if cells can acquire MNX1 at this stage (dashed arrow
in Figure S7). In addition to these endocrine progenitor
populations found at S4d3, pancreatic progenitors at this
stage are expressing MNX1 and NKX6.1, and give rise to
the population of newly formed endocrine progenitorshESC-derived INS+ cells for genes upregulated in b cells and hESC-
hESC-derived b-like cells (D), a-cell-specific genes (E), and genes
sent the 25th (Q1) and 75th (Q3) percentiles, and whiskers are at
lineages of b-like versus polyhormonal cells. The hES-derived cells
ifferentiation, carried out on different days, in similar proportions.
pression.
present at S4d3, which are MNX1+ and NKX6.1+. These
cells also express FEV but not ISL1.
In summary, we suggest that MNX1 expression in
early NKX6.1 endocrine progenitors mark cells that will
become NKX6.1+, while FEV expression preceding ISL1
initiation is also marking this fate choice (Figure 7G). We
propose that this differentiation path is feeding into the
lineage fated to a b-like cell type in parallel with endocrine
cells derived fromNKX6.1+/MNX1+ pancreatic progenitors.
Discrete populations along this path can be found at each
stage, as outlined in Figure 3A and detailed in Figure S7.
The polyhormonal-fated cells mature in parallel, and are
characterized at the end stage by their expression of ARX,
while having no PCSK1 or HADH (Figure S7). Our work
thus identifies both lineage bifurcations and conver-
gence of different paths to the same fate. Our functional
assay demonstrated that NKX6.1 can be acquired after
NEUROG3, and further indicated that NEUROG3 cells
forming during stage 5 are born from both NKX6.1+ and
NKX6.1 cells. Thereby it seems that the path in which
NKX6.1 is expressed downstream of NEUROG3 is not a
phenomenon restricted to stage-4 endocrine differentia-
tion, but that both pathways (NKX6.1 expression before
or after NEUROG3) are active throughout differentiation.
Studies in both mouse (Nelson et al., 2007; Schaffer et al.,
2013; Taylor et al., 2013) and hESC-derived pancreatic
cell populations (Kelly et al., 2011; Kroon et al., 2008; Reza-
nia et al., 2013; Russ et al., 2015) have led to the assump-
tion that mature b cells derive from endocrine progenitors
born out of NKX6.1+ pancreatic progenitors. This, how-
ever, has not been unequivocally tested by specific interfer-
ence solely in these cells, and our findings indicate that the
onset of NKX6.1 in the endocrine progenitor population
also enables b-cell differentiation.What triggers this induc-
tion deserves more investigations.
Maturation of In-Vitro-Derived Endocrine Cells
At stage 5 we observed high INS expression levels and
NKX6.1 expression in most endocrine committed cells,
while GCG transcripts were still low or absent from about
half of these cells. These findings indicate that the earliest
endocrine cells express insulin alone, preceding the forma-
tion of polyhormonal cells, in agreement with the detec-
tion of insulin first in human embryos (Riedel et al.,
2012). However, all endocrine cells present at the end stage
of differentiation transcriptionally co-expressed multiple
hormones, most notably INS and GCG. These are not back-
ground levels as they are much higher than in pancreas
progenitors. A tendency to mixed a- and b-cell signatures
has been seen in newly born islets but not in the adult
(Wang et al., 2016), which suggests that a window of plas-
ticity may exist until early post-natal development in hu-
mans. While INSwas expressed at high levels in most cells,the levels of GCG transcript were more variable, and high
expression was observed only in cells that co-expressed
ARX and had low levels of NKX6.1 and PDX1. When
comparing the in-vitro-derived INS+ cells with human pri-
mary a and b cells, we also detected glucagon transcripts
in primary b cells, though at lower level than found in
the hESC-derived b-like cells. Since most cells are not poly-
hormonal at the protein level, this suggests post-transcrip-
tional regulation. A possible scenario may imply different
processing of proglucagon and proinsulin. The proconver-
tases PCSK1 and PCSK2 are both required for proper con-
version of proinsulin into insulin and C-peptide, while
only PCSK2 is needed in a cells to produce glucagon. In
cells co-expressing PCSK1 and PCSK2, the incretin GLP-1
would be expected instead. While PCSK2 is expressed
in almost all endocrine cells produced in vitro, PCSK1
expression is variable. Thus, the ARX+ cells with high levels
of GCG and INS transcript only express PCSK2, and would
be expected to partially process proinsulin and mature
glucagon. Conversely, the b-like cells might produce
mature insulin (and cleaved C-peptide) along with GLP-1
or glucagon depending of their levels of PCSK1. As the
C-peptide targeting antibodies used in this study and
most others also target proinsulin and partially processed
proinsulin (Asadi et al., 2015), our analysis for C-peptide
protein can likely not distinguish between these forms.
Our single-cell qPCR analysis of human islets confirmed
many signature genes for the a, b, and PP cells identified in
recent single-cell RNA-seq publications. Single-cell qPCR
appears to be more sensitive than single-cell RNA-seq, as
evidenced by, e.g., the robust detection of MAFA in all
b cells. Finally, we identified b- and a-cell-specific expres-
sion of SIM1, a factor not previously described in human
islet cells. Our comparison between hESC-derived INS+ cells
and human primary a and b cells reveal several genes that
were expressed at similar level between mature b-like cells
and human b cells, including PTCH1, RUNX1T1, TSPAN1,
RGS16, DLK1, PDX1, MNX1, and NKX6.1. We further
found genes enriched in primary b cells, including IAPP,
MAFA, HDAC9, HADH, and GPM6A, while KRT19, FEV,
and PRDM16 were enriched in hESC-derived b-like cells.
GPM6A was exclusively found in primary b cells. While
GPM6A was not expressed in INS+ hESC-derived cells,
it was expressed in pancreatic progenitors during stage 4
and in newly born endocrine progenitors. Interestingly,
GPM6A, a membrane glycoprotein, may represent a new
marker that is missing from in-vitro-generated b-like cells
that could be used as readout for maturation.
While similar hPSC models of brain and mesoderm dif-
ferentiation have also identified subpopulations marking
discrete maturation stages and bifurcations (Bargajea et al.,
2017; Yao et al., 2016), the pancreas model shows that mul-
tiple paths can be taken in vitro to the same fate. It will beStem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017 1259
important to investigate whether this is pertinent to other
organs and lineages and to what extent this is conserved
in vivo. While we compared cells produced in vitro with
the adult cell types, comparisons with samples fromhuman
fetuses will substantiate whether the lineage specification
mechanisms established in vitro recapitulate states that can
be observed in vivo.EXPERIMENTAL PROCEDURES
Human Islets and hPSCs
Human islets were obtained from Prodo Laboratories (Irvine, CA)
with informed consent. hPSCsweremaintained on hESC-qualified
Matrigel in mTeSR-1 (see Supplemental Experimental Procedures).
Experiments with human stem cells were conducted with the
approval of the Science Ethical Committee of the Copenhagen
region.
Differentiation of hPSCs
Differentiation of hPSCs to b-like cells was performed essentially
as described in Rezania et al. (2014) or for differentiation toward
polyhormonal cells, as described by Rezania et al. (2012). For de-
tails on medium composition, number of days, and factors used
throughout the differentiation protocols, see Supplemental Exper-
imental Procedures.
Sorting of Human Islets and NEUROG3-EGFP Cells
Differentiated hESCs were dissociated to single cells with TrypLE
Select and human islets with Accutase (PAA Laboratories), and
stained with DAPI to discriminate dead cells. Cells were sorted
on a BD FACSAria Fusion cell sorter (BD Biosciences) using a
100-mm nozzle. For single-cell qPCR cells were sorted directly
into 96-well PCR plates containing NP40 Detergent Surfact-
Amps solution (Fisher Scientific), SUPERase-In RNase Inhibitor
(Ambion), Superscript VILOcDNA Synthesis reactionmix (Invitro-
gen), and nuclease-free water. Plates were sealed, briefly centri-
fuged, and stored at 80C until performing single-cell qPCR.
Sorting of live NEUROG3-EGFP cells for subsequent culture is
described in Supplemental Experimental Procedures.
Flow Cytometry and Immunofluorescence Imaging
For flow cytometry, differentiated hESCs were dissociated with
TrypLE Select to a single-cell solution and fixed and stained for
various intracellular markers. For immunofluorescence imaging,
differentiated hESCs were fixed and stained directly in the wells
of the culture plates. Supplemental Experimental Procedures pro-
vides additional details and antibody information.
Single-Cell qPCR
Reverse transcription, specific target amplification, and qPCR
were performed according to the manufacturer’s instructions (Flu-
idigm, protocol no. 68000088_G1, appendix B). Details on mate-
rials, their concentration, primer validation, initial processing of
the data, quality control, and data analysis are described in Supple-
mental Experimental Procedures.1260 Stem Cell Reports j Vol. 9 j 1246–1261 j October 10, 2017Statistics
For single-cell analysis, each cell was treated as a biological
replicate. Error bars in the figures indicate SD or SEM as indicated
in the legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, seven figures, and one data file and can be found
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